BR0307122A - nucleic acid encoding a protein-coupled receptor and its uses - Google Patents

nucleic acid encoding a protein-coupled receptor and its uses

Info

Publication number
BR0307122A
BR0307122A BR0307122-7A BR0307122A BR0307122A BR 0307122 A BR0307122 A BR 0307122A BR 0307122 A BR0307122 A BR 0307122A BR 0307122 A BR0307122 A BR 0307122A
Authority
BR
Brazil
Prior art keywords
protein
nucleic acid
acid encoding
coupled receptor
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
BR0307122-7A
Other languages
Portuguese (pt)
Inventor
Haifeng Eishingdrelo
Jidong Cai
Anthony Sandrasagra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0210597.1A external-priority patent/GB0210597D0/en
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of BR0307122A publication Critical patent/BR0307122A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"áCIDO NUCLéICO CODIFICANDO UM RECEPTOR ACOPLADO à PROTEìNA G E SEUS USOS". A presente invenção refere-se a um receptor acoplado à proteína G útil que está envolvido na transdução de sinal com relação à inflamação e resposta imunológica fisiológica. São também providos métodos de uso do receptor para avaliar moléculas que podem modular a atividade do receptor. Tais moléculas podem imediatamente ter aplicações no tratamento de uma pletora de inflamação e doenças e distúrbios imunologicamente relacionados."NUCLEIC ACID ENCODING A RECEIVER COUPLED WITH PROTEIN G AND ITS USES". The present invention relates to a useful G-protein coupled receptor that is involved in signal transduction with respect to inflammation and physiological immune response. Methods of using the receptor to evaluate molecules that can modulate receptor activity are also provided. Such molecules may immediately have applications in the treatment of a plethora of inflammation and immunologically related diseases and disorders.

BR0307122-7A 2002-01-23 2003-01-21 nucleic acid encoding a protein-coupled receptor and its uses Withdrawn BR0307122A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35100602P 2002-01-23 2002-01-23
GBGB0210597.1A GB0210597D0 (en) 2002-01-23 2002-05-09 A nucleic acid encoding a G-protein-coupled receptor,and uses thereof
PCT/US2003/001694 WO2003061365A2 (en) 2002-01-23 2003-01-21 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof

Publications (1)

Publication Number Publication Date
BR0307122A true BR0307122A (en) 2004-12-28

Family

ID=27614811

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307122-7A Withdrawn BR0307122A (en) 2002-01-23 2003-01-21 nucleic acid encoding a protein-coupled receptor and its uses

Country Status (8)

Country Link
EP (1) EP1470420A4 (en)
JP (1) JP2005514934A (en)
BR (1) BR0307122A (en)
CA (1) CA2473707A1 (en)
MX (1) MXPA04007117A (en)
NO (1) NO20043123L (en)
RU (1) RU2004125608A (en)
WO (1) WO2003061365A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083388A2 (en) 2003-03-14 2004-09-30 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1575601A (en) * 1999-10-27 2001-05-08 Pharmacia & Upjohn Company G protein-coupled receptors expressed in brain
IL149569A0 (en) * 1999-11-17 2002-11-10 Arena Pharm Inc Endogenous and non-endogenous versions of human g protein-coupled receptors
WO2001094385A2 (en) * 2000-06-05 2001-12-13 Bayer Aktiengesellschaft Human hm74-like g protein coupled receptor

Also Published As

Publication number Publication date
MXPA04007117A (en) 2005-02-25
RU2004125608A (en) 2005-04-20
WO2003061365A3 (en) 2003-11-13
NO20043123L (en) 2004-07-20
EP1470420A4 (en) 2005-08-24
JP2005514934A (en) 2005-05-26
WO2003061365A2 (en) 2003-07-31
CA2473707A1 (en) 2003-07-31
EP1470420A2 (en) 2004-10-27

Similar Documents

Publication Publication Date Title
Moulin et al. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells
Krueger et al. Peptidoglycans as promoters of slow-wave sleep. II. Somnogenic and pyrogenic activities of some naturally occurring muramyl peptides; correlations with mass spectrometric structure determination.
Proost et al. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation
Peng et al. Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity
Petes et al. Interleukin (IL)-6 inhibits IL-27-and IL-30-mediated inflammatory responses in human monocytes
ATE442385T1 (en) INTERLEUKIN-17 RECEPTOR-LIKE PROTEIN
BRPI0410741A (en) immunosuppressive compound and compositions
BRPI0407401A (en) bicyclic compounds and compositions
ATE182901T1 (en) DNA CODING FOR ANDROGEN RECEPTOR PROTEIN
Okazaki et al. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator
ATE233813T1 (en) MODIFIED IMMUNOLOBULINS FOR SPECIFIC FC-EPSILON RECEPTORS
PT910647E (en) Human dnase i hyperactive variants
Xu et al. The potential role of mechanically sensitive ion channels in the physiology, injury, and repair of articular cartilage
DE69636437D1 (en) LIGAND POLYPEPTIDE FOR HYPOPHYSE G PROTEIN COUPLED RECEPTOR PROTEIN, THEIR PREPARATION AND APPLICATION
BR9811093A (en) Pyridines replaced with 2-amino-6- (2-substituted 4-phenoxy)
BR0316923A (en) Mitoneet polypeptide of mitochondrial membranes, their modulators and methods for their use
ATE290080T1 (en) HUMAN BETA-9 CHEMOKINE
Klatt et al. Matrilin-3 activates the expression of osteoarthritis-associated genes in primary human chondrocytes
Naruishi et al. Impairment of gingival fibroblast adherence by IL-6/sIL-6R
BR9807085A (en) Il-8 receptor antagonists
Saviano et al. New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function
BR0307122A (en) nucleic acid encoding a protein-coupled receptor and its uses
BR0307707A (en) nucleic acid encoding a g-protein coupled receptor and using it
DE69131133D1 (en) USE OF GRO GENES AND PROTEINS
EE03483B1 (en) 4-Amino-tetrahydro-benzisoxazole or isothiazole compounds, their use in the preparation of pharmaceutical preparations and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 4O, 5O, 6O E 7O ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2047 DE 30/03/2010.